LobbyingBreakthrough T1D lobbying by quarter
Breakthrough T1D's latest lobbying report covers Q2 2026, at $80K. The four quarters Q4 2025–Q3 2026 total $240K. Its first report covers Q4 2022; the issues it reports most are Budget/Appropriations and Health Issues.
Breakthrough T1D
- Latest quarter
- No record
- Q3 2026 · 0 reports
- Last 12 months
- $240K
- Last 4 quarters
- vs last quarter
- −100.0%
- Q3 2026 against the quarter before
- First report
- Q4 2022
- The first quarter a report named it
Lobbying by quarter
| Quarter | Amount | Reports |
|---|---|---|
| Q4 2022 | $80K | 1 |
| Q1 2023 | $80K | 1 |
| Q2 2023 | $80K | 1 |
| Q3 2023 | $80K | 1 |
| Q4 2023 | $80K | 1 |
| Q1 2024 | $80K | 1 |
| Q2 2024 | $80K | 1 |
| Q3 2024 | $80K | 1 |
| Q4 2024 | $80K | 1 |
| Q1 2025 | $80K | 1 |
| Q2 2025 | $80K | 1 |
| Q3 2025 | $80K | 1 |
| Q4 2025 | $80K | 1 |
| Q1 2026 | $80K | 1 |
| Q2 2026 | $80K | 1 |
| Q3 2026 | $0 | 0 |
By issue
- Budget and appropriations$533.3K · 15 reports
- Health issues$533.3K · 15 reports
- Medicare and Medicaid$133.3K · 5 reports
An issue's amount splits each report's amount equally over the issues the report lists.
Who was lobbied
- Food & Drug Administration (FDA)15 reports
- Health & Human Services, Dept of (HHS)15 reports
- HOUSE OF REPRESENTATIVES15 reports
- SENATE15 reports
- Centers For Medicare and Medicaid Services (CMS)5 reports
Firms it paid
| Firm | ||
|---|---|---|
| Tarplin, Downs & Young | $1.2M | 15 quarters |
Former officials lobbying for it
| Former position | ||
|---|---|---|
| ELIZABETH T MURRAY | Senior Policy Advisor, Democratic Whip Steny Hoyer; Legislative Asst. for Rep. Mike Thompson, Rep. Bob Matsui, and Senator Bob Graham | Q2 2026 |
| JEFF RECZEK | Dir. CDC Washington, Professional Staff Sen. Appropriations Cmte, Program Examiner OMB, Program Analyst Dept. of Transportation | Q2 2026 |
| JENNIFER B YOUNG | Asst. Sec. for Leg. - HHS; Dep. Asst. Sec. for Leg. - HHS; Cmte. Staff, House Cmte. on Ways and Means; Cmte. Staff, Sen. Cmte. on Finance | Q2 2026 |
| MARGARET JOSEPH | CoS for Sen. Kyrsten Sinema, CoS for Rep. Kyrsten Sinema, CoS for Rep. Bobby Bright, CoS for Rep. Jim Matheson, Clerk for House Rules Cmte. | Q2 2026 |
| PAMELA SMITH | Leg. Dir., Sen. Tom Harkin; Dep. Staff Dir., Senate HELP Cmte; Staff Dir., Senate HELP Cmte; Counselor to the Asst. AG, Civil Div., Dept of Justice; Spec Counsel, Ofc of Leg. Affairs, Dept of Justice; Counsel and LA, Senator Carol Moseley-Braun | Q2 2026 |
| RAISSA H DOWNS | Prin. Dep. Asst. Sec. for Leg. - HHS; Dep. Asst. Sec. for Leg. - HHS; Staff Dir., Sub. Cmte. on Employment, Sen. HELP Cmte. | Q2 2026 |
| LAURA FRIEDEL | Leg. Asst., Sen. Zell Miller, Leg. Dir., Sen. Richard Shelby, Clerk, Staff Dir., Sen. Appropriations Committee | Q3 2025 |
| CHARLOTTE SPEARS IVANCIC | Legislative Counsel, Senator Jim DeMint; Health Counsel, Majority Leader Bill Frist; Counsel and Budget Analyst, House Budget Committee; Asst. to the Speaker for Policy, Speaker John Boehner | Q4 2024 |
| EMILY H MURRY | Staff Dir., Sub. Cmte. on Health, W&M Cmte; Sr. Policy Advisor, Majority Leader McCarthy; Policy Advisor, Majority Whip McCarthy; Professional Staff, Republican Study Cmte.; Leg. Aid, Rep. Ken Calvert; Leg. Asst., Rep. Tom Price | Q4 2024 |
| KIMBERLY LYNN BRANDT | Sr. Counsel and Dir. External Affairs - HHS OIG; Prin. Dep. Administrator for Policy and Operations and Dir. of Medicare Program Integrity - CMS; Chief Oversight and General Counsel - Senate Cmte. on Finance | Q4 2024 |
| PARICK BRAERTON CARROLL | Leg Asst. Rep. Ray LaHood, Leg Dir. Rep. Kevin Yoder, PSM Senate Appropriations Cmte. | Q4 2024 |
| PETER FISE | Health Counsel for Sen. Cmte on Finance, Health Counsel for Sen. Jeanne Shaheen, Staff Assistant for House Cmte on Oversight & Government Reform | Q4 2024 |
| MICHELLE P EASTON | Chief Health Counsel, Sen. Cmte. on Finance; Staff Dir., Senate Aging Cmte.; Leg. Asst., Congressman Billy Tauzin | Q4 2022 |
Lobbying reports
| Filed by | ||
|---|---|---|
| 07/20for Q2 | Tarplin, Downs & Young | $80K |
| 04/20for Q1 | Tarplin, Downs & Young | $80K |
| 01/20for Q4 2025 | Tarplin, Downs & Young | $80K |
| 25/10/16for Q3 2025 | Tarplin, Downs & Young | $80K |
| 25/07/17for Q2 2025 | Tarplin, Downs & Young | $80K |
| 25/04/21for Q1 2025 | Tarplin, Downs & Young | $80K |
| 25/01/21for Q4 2024 | Tarplin, Downs & Young | $80K |
| 24/10/21for Q3 2024 | Tarplin, Downs & Young | $80K |
| 24/07/17for Q2 2024 | Tarplin, Downs & Young | $80K |
| 24/04/22for Q1 2024 | Tarplin, Downs & Young | $80K |
| 24/04/16for Q1 2024 | Tarplin, Downs & Young | $80K |
| 24/02/07for Q4 2022 | Tarplin, Downs & Young | $80K |
| 24/01/18for Q4 2023 | Tarplin, Downs & Young | $80K |
| 24/01/18for Q4 2023 | Tarplin, Downs & Young | $80K |
| 23/10/20for Q3 2023 | Tarplin, Downs & Young | $80K |
| 23/07/17for Q2 2023 | Tarplin, Downs & Young | $80K |
| 23/04/20for Q1 2023 | Tarplin, Downs & Young | $80K |
| 23/01/20for Q4 2022 | Tarplin, Downs & Young | $80K |